Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6376
CALL
Flowserve
FLS
$10.3B
| $1.36M | ﹤0.01% |
23,700
+19,800
| +508% | +$1.14M |
|
6377
PUT
Green Plains
GPRE
$1.09B
| $1.36M | ﹤0.01% |
143,700
-52,900
| -27% | -$596K |
|
|
IPG
6378
PUT
DELISTED
Interpublic Group of Companies
IPG
| $1.36M | ﹤0.01% |
48,600
+24,500
| +102% | +$731K |
|
6379
CALL
Bread Financial
BFH
$4.5B
| $1.36M | ﹤0.01% |
22,300
-800
| -3% | -$45.2K |
|
6380
Adaptive Biotechnologies
ADPT
$3.94B
| $1.36M | ﹤0.01% |
226,982
+17,556
| +8% | +$96.8K |
|
6381
CALL
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $1.36M | ﹤0.01% |
56,500
-78,500
| -58% | -$1.9M |
|
6382
Franklin US Core Bond ETF
FLCB
$3.05B
| $1.36M | ﹤0.01% |
64,450
+2,169
| +3% | +$46.4K |
|
6383
Aquestive Therapeutics
AQST
$533M
| $1.36M | ﹤0.01% |
381,678
-490,155
| -56% | -$2.26M |
|
|
6384
Green Plains
GPRE
$1.09B
| $1.36M | ﹤0.01% |
143,259
-344,660
| -71% | -$3.88M |
|
|
LKFT
6385
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $1.36M | ﹤0.01% |
49,373
-8,601
| -15% | -$240K |
|
6386
AudioCodes
AUDC
$245M
| $1.36M | ﹤0.01% |
139,343
-27,454
| -16% | -$253K |
|
6387
CALL
FTI Consulting
FCN
$4.19B
| $1.36M | ﹤0.01% |
7,100
+2,500
| +54% | +$515K |
|
6388
PUT
Surgery Partners
SGRY
$1.97B
| $1.36M | ﹤0.01% |
64,100
-14,400
| -18% | -$378K |
|
6389
Resideo Technologies
REZI
$3.13B
| $1.36M | ﹤0.01% |
58,855
-1,166,340
| -95% | -$27.4M |
|
|
ESPR
6390
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.36M | ﹤0.01% |
616,300
+246,900
| +67% | +$576K |
|
6391
Seaboard Corp
SEB
$4.18B
| $1.36M | ﹤0.01% |
+558
| New | +$1.53M |
|
6392
Worthington Steel
WS
$1.93B
| $1.35M | ﹤0.01% |
42,578
-163,014
| -79% | -$6.36M |
|
6393
Bally's
BALY
$685M
| $1.35M | ﹤0.01% |
+75,714
| New | +$1.34M |
|
6394
CALL
Trex
TREX
$4.97B
| $1.35M | ﹤0.01% |
19,600
-73,700
| -79% | -$5.19M |
|
6395
PUT
Madison Square Garden
MSGE
$4.04B
| $1.35M | ﹤0.01% |
38,000
-9,300
| -20% | -$359K |
|
6396
Fidelity MSCI Energy Index ETF
FENY
$2.11B
| $1.35M | ﹤0.01% |
56,680
-38,970
| -41% | -$976K |
|
6397
PUT
ABM Industries
ABM
$2.82B
| $1.35M | ﹤0.01% |
26,400
-700
| -3% | -$38.1K |
|
6398
CALL
ACV Auctions
ACVA
$1.29B
| $1.35M | ﹤0.01% |
62,500
+18,800
| +43% | +$380K |
|
6399
Franklin Disruptive Commerce ETF
BUYZ
$5.42M
| $1.35M | ﹤0.01% |
36,574
+6,495
| +22% | +$239K |
|
6400
MeiraGTx Holdings
MGTX
$1.3B
| $1.35M | ﹤0.01% |
221,340
+20,507
| +10% | +$120K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.